Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Language English, Spanish Country Spain Media print-electronic
Document type Journal Article
PubMed
38220587
DOI
10.1016/j.arbres.2023.12.016
PII: S0300-2896(23)00421-0
Knihovny.cz E-resources
- Keywords
- Anticoagulation, Bleeding, Mortality, Pulmonary embolism, Recurrences, Venous thromboembolism,
- MeSH
- Anticoagulants therapeutic use MeSH
- Hemorrhage epidemiology etiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Embolism * drug therapy epidemiology MeSH
- Recurrence MeSH
- Registries MeSH
- Aged MeSH
- Venous Thromboembolism * drug therapy epidemiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anticoagulants MeSH
INTRODUCTION: Although older adults represent a significant proportion of patients with venous thromboembolism (VTE), the data on the impact of age-related differences in the clinical presentation, management, and outcomes of VTE are scarce. METHODS: We analyzed data from the RIETE registry database, an ongoing global observational registry of patients with objectively confirmed VTE, to compare patient characteristics, clinical presentation, treatments, and outcomes between elderly (≥70 years) vs. non-elderly (<70 years) patients. RESULTS: From January 2001 to March 2021, 100,000 adult patients were enrolled in RIETE. Elderly patients (47.9%) were more frequently women (58.2% vs. 43.5%), more likely had unprovoked VTE (50.5% vs. 45.1%) and most often presented with severe renal failure (10.2% vs. 1.2%) and acute pulmonary embolism (PE) (vs. deep vein thrombosis) (54.3% vs. 44.5%) compared to non-elderly patients (p<0.001 for all comparisons). For the PE subgroup, elderly patients more frequently had non-low risk PE (78.9% vs. 50.7%; p<0.001), respiratory failure (33.9% vs. 21.8%; p<0.001) and myocardial injury (40.0% vs. 26.2%; p<0.001) compared to non-elderly patients. Thrombolysis (0.9% vs. 1.7%; p<0.001) and direct oral anticoagulants (8.8% vs. 11.8%; p<0.001) were less frequently administered to elderly patients. Elderly patients showed a significantly higher 30-day all-cause mortality (adjusted odds ratio [OR] 1.36, 95%CI: 1.22-1.52) and major bleeding (OR, 2.08; 95%CI, 1.85-2.33), but a lower risk of 30-day VTE recurrences (OR, 0.62, 95%CI, 0.54-0.71). CONCLUSIONS: Compared with non-elderly patients, elderly patients had a different VTE clinical profile. Advanced therapies were less frequently used in older patients. Age was an independent predictor of mortality.
Department of Angiology Azienda Ospedaliera Universitaria Parma Italy
Department of Cardiology Massachusetts General Hospital Boston MA USA
Department of Internal Medicine Hospital de Mataró Barcelona Spain
Department of Internal Medicine Hospital Universitario La Paz Madrid Spain
Emergency Department Hospital Dr Peset Valencia Spain
References provided by Crossref.org